Flumetasone
Systematic (IUPAC) name | |
---|---|
(1R,2S,8S,10S,11S,13R,14R,15S,17S)-1,8-difluoro-14,17-dihydroxy-14-(2-hydroxyacetyl)-2,13,15-trimethyltetracyclo[8.7.0.02,7.011,15]heptadeca-3,6-dien-5-one | |
Clinical data | |
AHFS/Drugs.com | Micromedex Detailed Consumer Information |
Routes of administration | Topical |
Pharmacokinetic data | |
Metabolism | Hepatic, CYP3A4-mediated |
Identifiers | |
CAS Number | 2135-17-3 |
ATC code | D07AB03 , D07XB01 (combinations), QH02AB90 |
PubChem | CID 16490 |
ChemSpider | 15632 |
UNII | LR3CD8SX89 |
KEGG | D04208 |
ChEBI | CHEBI:34764 |
ChEMBL | CHEMBL1201392 |
Synonyms | Flumethasone |
Chemical data | |
Formula | C22H28F2O5 |
Molar mass | 410.452 g/mol |
| |
| |
(what is this?) (verify) |
Flumetasone (INN; or flumethasone) is a corticosteroid for topical use. Trade names include Locacorten, Locorten, and Orsalin. It is available in combination with clioquinol, under the trade name Locacorten-Vioform (in some countries Locorten-Vioform), for the treatment of otitis externa and otomycosis. It is usually formulated as the pivalic acid ester prodrug flumetasone pivalate.
Flumethasone is 420 times as potent as cortisone in an animal model for anti-inflammatory activity.
See also
References
|
This article is issued from Wikipedia - version of the Friday, February 26, 2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.